glp 1 receptors PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Glucagon-like peptide-1 - Wikipedia
Description
Personalized medicine: Given the individual variability in response to GLP-1 agonists, personalized treatment plans are becoming increasingly important
Semaglutide, generally, has shown greater efficacy in weight loss compared to Liraglutide in clinical trials
Newer drugs such as tirzepatide (Mounjaro, Zepbound) target GLP1 and GIP (dual agonist)
Physicians consider them "game-changers" for eligible patients due to their superior efficacy compared to other options like Orlistat
The focus is often on managing obesity as a medical condition, rather than purely cosmetic weight loss
